EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 95 filers reported holding EPIZYME INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $363,000 | +1196.4% | 24,687 | 0.0% | 0.21% | +34.2% |
| Q1 2022 | $28,000 | -54.8% | 24,687 | 0.0% | 0.16% | -52.2% |
| Q4 2021 | $62,000 | -50.8% | 24,687 | 0.0% | 0.32% | -52.9% |
| Q3 2021 | $126,000 | -38.5% | 24,687 | 0.0% | 0.69% | +7544.4% |
| Q2 2021 | $205,000 | -4.7% | 24,687 | 0.0% | 0.01% | +12.5% |
| Q1 2021 | $215,000 | -19.8% | 24,687 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $268,000 | -9.2% | 24,687 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $295,000 | -25.5% | 24,687 | 0.0% | 0.01% | -50.0% |
| Q2 2020 | $396,000 | +123.7% | 24,687 | +75.1% | 0.01% | +100.0% |
| Q2 2019 | $177,000 | -9.7% | 14,099 | +35.7% | 0.01% | +40.0% |
| Q4 2014 | $196,000 | -30.5% | 10,393 | 0.0% | 0.01% | -37.5% |
| Q3 2014 | $282,000 | – | 10,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |